{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:01:11Z","timestamp":1790622071253,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 25K13227"],"award-info":[{"award-number":["JP 25K13227"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Radiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11282-026-00950-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:03:13Z","timestamp":1784617393000},"page":"1295-1303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple myeloma diagnosed after contrast-enhanced computed tomography without renal complications: a case report with literature review"],"prefix":"10.1007","volume":"42","author":[{"given":"Keiko","family":"Kudoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Kudoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Tsunematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Tonoiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Otomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naito","family":"Kurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"950_CR1","first-page":"241","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"RW McKenna","year":"2017","unstructured":"McKenna RW, Kyle RA, Kuehi WM, Harris NL, Coupland RW, Fend F. Plasma cell neoplasms. In: Swerdlow SH, editor. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017. p. 241\u201353."},{"key":"950_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/jnci\/djae321","volume":"117","author":"A Mafra","year":"2022","unstructured":"Mafra A, Laversanne M, Marcos-Gragera R, Chaves HVS, McShane C, Bray F, et al. The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045. J Natl Cancer Inst. 2022;117:907\u201314.","journal-title":"J Natl Cancer Inst"},{"key":"950_CR3","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538-48.","journal-title":"Lancet Oncol"},{"key":"950_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bjh.14213","volume":"175","author":"K Yong","year":"2016","unstructured":"Yong K, Delforge M, Driessen C, Fink L, Flinois A, Gonzalez-McQuire S, et al. Multiple myeloma: patient outcomes in real-world practice. Br J Haematol. 2016;175:252\u201364.","journal-title":"Br J Haematol"},{"key":"950_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1148\/radiology.183.2.1561361","volume":"183","author":"CS McCarthy","year":"1992","unstructured":"McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology. 1992;183:519\u201321.","journal-title":"Radiology"},{"key":"950_CR6","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00330-016-4478-0","volume":"27","author":"SM Schreuder","year":"2017","unstructured":"Schreuder SM, Stoker J, Bipat S. Prediction of presence of kidney disease in patients undergoing intravenous iodinated contrast enhanced computed tomography: a validation study. Eur Radiol. 2017;27:1613\u201321.","journal-title":"Eur Radiol"},{"key":"950_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2214\/AJR.10.5152","volume":"196","author":"JK Pahade","year":"2011","unstructured":"Pahade JK, LeBedis CA, Raptopoulos VD, Avigan DE, Yam CS, Kruskal JB, et al. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. AJR Am J Roentgenol. 2011;196:1094\u2013101.","journal-title":"AJR Am J Roentgenol"},{"key":"950_CR8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s12253-017-0300-9","volume":"24","author":"MP Crowley","year":"2018","unstructured":"Crowley MP, Prabhakaran VN, Gilligan OM. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced procedures. Pathol Oncol Res. 2018;24:915\u20139.","journal-title":"Pathol Oncol Res"},{"key":"950_CR9","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.ejrad.2011.11.020","volume":"81","author":"J Kooiman","year":"2012","unstructured":"Kooiman J, Pasha SM, Zondag W, Sijpkens YW, van der Molen AJ, Huisman MV, et al. Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol. 2012;81:2554\u201361.","journal-title":"Eur J Radiol"},{"key":"950_CR10","doi-asserted-by":"publisher","first-page":"F451","DOI":"10.1152\/ajprenal.90576.2008","volume":"297","author":"JM Huber","year":"2009","unstructured":"Huber JM, Tagwerker A, Heininger D, Mayer G, Rosenkranz AR, Eller K. The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2009;297:F451-60.","journal-title":"Am J Physiol Renal Physiol"},{"key":"950_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2214\/AJR.05.0407","volume":"186","author":"BM Elicker","year":"2006","unstructured":"Elicker BM, Cypel YS, Weinreb JC. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR Am J Roentgenol. 2006;186:1651\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"950_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0029-1230995","volume":"129","author":"G Baltzer","year":"1978","unstructured":"Baltzer G, Jacob H, Esselborn H, Gassel WD. Contrast media and renal function in multiple myeloma: a retrospective study. Rofo. 1978;129:208\u201311.","journal-title":"Rofo"},{"key":"950_CR13","doi-asserted-by":"crossref","unstructured":"Stacul F, Bertolotto M, Thomsen HS, Pozzato G, Ugolini D, Bellin MF, Bongartz G, Clement O, Heinz-Peer G, van der Molen A, Reimer P, Webb JAW; ESUR Contrast Media Safety Committee. Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2018;28:683\u201391.","DOI":"10.1007\/s00330-017-5023-5"},{"key":"950_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-0029-1230458","volume":"125","author":"D Catalano","year":"1976","unstructured":"Catalano D, Valente A, Fucci G. Waldenstr\u00f6m macroglobulinaemia and intravenous contrast media. Rofo. 1976;125:262\u20133.","journal-title":"Rofo"},{"key":"950_CR15","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220009","volume":"95","author":"YJ Huh","year":"2022","unstructured":"Huh YJ, Lee SY, Kim S, Lee SE, Jung JY. Differentiation of multiple myelomas from osteolytic bone metastases: diagnostic value of tumor homogeneity on contrast-enhanced CT. Br J Radiol. 2022;95:20220009.","journal-title":"Br J Radiol"},{"key":"950_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-27742-0","volume-title":"Contrast Media: Safety Issues and ESUR Guidelines","author":"HS Thomsen","year":"2006","unstructured":"Thomsen HS. Contrast Media: Safety Issues and ESUR Guidelines. 3rd ed. Berlin: Springer; 2006.","edition":"3rd ed"},{"key":"950_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","volume":"178","author":"AH Mahnken","year":"2002","unstructured":"Mahnken AH, Wildberger JE, Gehbauer G, Schmitz-Rode T, Blaum M, Fabry U, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol. 2002;178:1429\u201336.","journal-title":"AJR Am J Roentgenol"},{"key":"950_CR18","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2026.0001","volume":"24","author":"SK Kumar","year":"2026","unstructured":"Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, et al. Multiple myeloma, version 5.2026, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2026;24:e260001.","journal-title":"J Natl Compr Canc Netw"},{"key":"950_CR19","unstructured":"National Cancer Center Japan. Cancer statistics: multiple myeloma. 2026. Available from: http:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/cancer\/26_mm.html."},{"key":"950_CR20","unstructured":"National Cancer Center Japan. Cancer statistics: oral cancer. 2026. Available from: http:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/cancer\/3_oral.html."},{"key":"950_CR21","volume":"2014","author":"A Romano","year":"2014","unstructured":"Romano A, Marescalco MS, Liardo C, Villari L, Vetro C, Conticello C, et al. Oral lesion as unusual first manifestation of multiple myeloma: case reports and review of the literature. Case Rep Hematol. 2014;2014:529452.","journal-title":"Case Rep Hematol"},{"key":"950_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/1754-9485.12177","volume":"58","author":"N Tejani","year":"2014","unstructured":"Tejani N, Cooper A, Rezo A, Pranavan G, Yip D. Numb chin syndrome: a case series of a clinical syndrome associated with malignancy. J Med Imaging Radiat Oncol. 2014;58:700\u20135.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"950_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11282-023-00701-x","volume":"39","author":"C Sugawara","year":"2023","unstructured":"Sugawara C, Takahashi A. Orofacial symptoms suggestive of malignant lesions and the role of imaging: literature review and case presentation. Oral Radiol. 2023;39:599\u2013613.","journal-title":"Oral Radiol"},{"key":"950_CR24","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.radcr.2026.01.109","volume":"21","author":"N Kamei","year":"2026","unstructured":"Kamei N, Asayama Y, Kubota Y, Kaku N, Moroga Y, Ogata M, et al. Primary bone lymphoma with extensive imaging-defined necrosis on magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography: a diagnostic pitfall. Radiology Case Reports. 2026;21:2081\u20136.","journal-title":"Radiology Case Reports"},{"key":"950_CR25","unstructured":"https:\/\/cdn.jsn.or.jp\/data\/guideline-201911.pdf"},{"key":"950_CR26","unstructured":"ACR Manual on Contrast Media. 2026. https:\/\/www.acr.org\/Clinical-Resources\/Clinical-Tools-and-Reference\/Contrast-Manual. Accessed 11 May 2026."},{"key":"950_CR27","unstructured":"RANZCR Iodinated Contrast Guidelines. 2018. https:\/\/www.ranzcr.com\/document\/iodinated-contrast-guidelines-2016\/. Accessed 11 May 2026."},{"key":"950_CR28","unstructured":"ESUR Guidelines on Contrast Agents 10.0. 2018. https:\/\/www.esur.org\/wp-content\/uploads\/2022\/03\/ESUR-Guidelines-10_0-Final-Version.pdf. Accessed 11 May 2026."},{"key":"950_CR29","unstructured":"Acute Kidney Injury prevention detection and management. 2013. https:\/\/www.nice.org.uk\/Guidance\/CG169. Accessed 11 May 2026."},{"key":"950_CR30","unstructured":"KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int(Suppl)2012;2: 1\u2012138. https:\/\/kdigo.org\/guidelines\/acute-kidney-injury\/"},{"key":"950_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.carj.2012.11.002","volume":"65","author":"RJ Owen","year":"2014","unstructured":"Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014;65:96\u2013105.","journal-title":"Can Assoc Radiol J"},{"key":"950_CR32","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1159\/000066641","volume":"93","author":"HS Trivedi","year":"2003","unstructured":"Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93:C29-34.","journal-title":"Nephron Clin Pract"},{"key":"950_CR33","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jacc.2006.11.034","volume":"27","author":"A Recio-Mayoral","year":"2007","unstructured":"Recio-Mayoral A, Chaparro M, Prado B, C\u00f3zar R, M\u00e9ndez I, Banerjee D, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO study. J Am Coll Cardiol. 2007;27:1283\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"950_CR34","unstructured":"Japanese Radiological Society. Guidelines for contrast media. 2025. Available from: http:\/\/www.radiology.jp\/content\/files\/20250416_02xcm.pdf."},{"key":"950_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejrad.2007.01.021","volume":"63","author":"JJW Sandstede","year":"2007","unstructured":"Sandstede JJW, Roth A, Machann W, Kaupert C, Hahn D. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography. Eur J Radiol. 2007;63:120\u20133.","journal-title":"Eur J Radiol"},{"key":"950_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/crad.2001.0849","volume":"57","author":"E Konen","year":"2002","unstructured":"Konen E, Konen O, Katz M, Levy Y, Rozenman J, Hertz M. Are referring clinicians aware of patients at risk from intravenous injection of iodinated contrast media? Clin Radiol. 2002;57:132\u20135.","journal-title":"Clin Radiol"},{"key":"950_CR37","unstructured":"Gunma University Hospital. Guidance for storage of samples. 2022. http:\/\/ciru.dept.showa.gunma-u.ac.jp\/guidance\/storage-sample\/pdf\/2022-061.pdf. Accessed 11 May 2026."}],"container-title":["Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11282-026-00950-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11282-026-00950-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11282-026-00950-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:26:38Z","timestamp":1790619998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11282-026-00950-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s11282-026-00950-6","relation":{},"ISSN":["0911-6028","1613-9674"],"issn-type":[{"value":"0911-6028","type":"print"},{"value":"1613-9674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}